Results 121 to 130 of about 82,921 (179)

Liver failure after treatment with inotuzumab and polychemotherapy including PEG-asparaginase in a patient with relapsed Philadelphia chromosome-negative acute lymphoblastic leukemia. [PDF]

Ann Hematol
Fischer D, Toenges R, Kiil K, Michalik S, Thalhammer A, Bug G, Gökbuget N, Lang F.   +7 more
europepmc   +1 more source

Retrospective cohort study monitoring PEG-asparaginase activity in acute lymphoblastic leukemia patients with and without premedication. [PDF]

F1000Res, 2019
Losasso M, Bostrom B, Messinger Y.
europepmc   +1 more source

Personalized nanomedicine: a rapid, sensitive, and selective UV-vis spectrophotometry method for the quantification of nanostructured PEG-asparaginase activity in children's plasma. [PDF]

Int J Nanomedicine, 2018
Zhang Y, Wang Y, Wang R, Shen Y, Xu J, Webster TJ, Fang Y.   +6 more
europepmc   +1 more source

Use of PEG-asparaginase in a case of Hepatosplenic γδ T-cell lymphoma with long-term remission after stem cell transplantation. [PDF]

Ecancermedicalscience, 2018
Sun K, Sanchez CG, Pingali SR, Iyer S.
europepmc   +1 more source

Use of PEG-asparaginase in monomorphic epitheliotropic intestinal T-cell lymphoma, a disease with diagnostic and therapeutic challenges. [PDF]

Ecancermedicalscience, 2017
Gentille C, Qin Q, Barbieri A, Ravi PS, Iyer S.   +4 more
europepmc   +1 more source

Thrombosis-Associated Risk Factors in Pediatrics and Adults Treated with Asparaginase-Containing Chemotherapy for ALL: A Systematic Review and Meta-Analysis. [PDF]

Curr Oncol
Seki JT, Atenafu EG, Sibai H.
europepmc   +1 more source

Weight Loss During Obesity Provokes Asparaginase-Associated Liver Steatosis and Endoplasmic Reticulum Stress. [PDF]

FASEB J
Bhavsar CT, Zalma BA, Tomoo K, Zhang Y, Lopez EM, Mirek ET, Dixon JL, Henderson GC, Wek RC, Anthony TG.   +9 more
europepmc   +1 more source